Table 1.
Demographic and clinical characteristics.
| M (SD) | n (%) | |
|---|---|---|
| Demographic Variables at Burst 1 | ||
| Age | 30.54 (5.59) | |
| Education (% with high school degree) | 43 (82.7%) | |
| Children (%) | 15 (28.8%) | |
| BMI | 22.61 (3.36) | |
| Psychotherapy | 9 (17.3%) | |
| SSRI intake | 0 (0%) | |
| Hormonal medication intake | 0 (0%) | |
| Relationship status (% in a relationship) | 25 (48.1%) | |
| Burst 1 | ||
| Cycle length during AA | 28.60 (3.47) | |
| PSST during Follicular Phase | 10.41 (9.40) | |
| PSST during Luteal Phase | 37.50 (9.79) | |
| Burst 2 | ||
| Psychotherapy start after burst 1 | 4 (7.7%) | |
| SSRI intake start after burst 1 | 1 (1.9%) | |
| Hormonal medication intake after burst 1 | 0 (0%) | |
| Cycle length during AA | 28.00 (2.34) | |
| PSST during Follicular Phase | 10.83 (11.21) | |
| PSST during Luteal Phase | 34.66 (11.01) | |
BMI, Body Mass Index; AA, Ambulatory Assessment; PSST, Premenstrual Symptoms Screening Tool; SSRI, Selective Serotonin Reuptake Inhibitor. PSST scores represent sum scores.